Mkango Resources (LON: MKA) is planning to combine its Songwe Hill rare earths project in Malawi with the Pulawy rare earth separation project in Poland and list them on Nasdaq as Mkango Rare Earths. This creates a vertically integrated rare earths business. The pro forma value of Mkango Resources’ shareholding would be $400m before any fundraising and transaction costs. The share price jumped 42.9% to 25p, the highest level for more than three years.
Alien Metals (LON: UFO) has identified significant iron mineralisation on the ridges of recently acquired areas of the Hancock iron ore project in Western Australia. An exploration target of up to 27 million tonnes and a grade of 62% iron has been defined after further exploration work. This is on top of existing resource estimates in other parts of the area and increases the strategic value of the project. The share price increased 24.2% to 0.1025p.
Rockfire Resources (LON: ROCK) is raising £2m at 0.1p/share, including a subscription of £1m by mining investor ACAM LP. This cash will finance development of the Molaoi zinc silver lead project in Greece. There should be an upgrade of the resource after further drilling. The resource should include an estimate for germanium, which would be the only known resource in Europe. The share price improved 18.2% to 0.0975p.
Ascent Resources (LON: AST) says the arbitration tribunal in Slovenia has rendered their final award in favour of the company in the cash against former joint venture partner Geoenergo. There is an additional awad of €4.99m plus interest since January 2024. The administrator of Geoenergo has already accepted a previous award of €2.89m. There is also an award for costs. The final payment received will depend on cash available after the administration. Other related disputes continue. The share price recovered 17.7% to 0.5p.
Crystal Amber Fund (LON: CRS) subsidiary Morphic Medical Inc has gained European regulatory approval for its RESET therapy, which is the first endoscopic, non-surgical treatment for obesity and type 2 diabetes. Initially the medical device will be launched in Germany. The share price rose 11.4% to 151p, which is the highest it has been for more than five years.
FALLERS
Online video editing technology developer Blackbird (LON: BIRD) has raised £2m from a placing and subscription at 3p/share and could raise up to £200,000 more from a retail offer. The cash will finance further development of the elevate.io platform and help to grow sales. There were 325 paid users at the end of May 2025 and the cost of adding each new user has more than halved to £115. The cost for signing up a free user is £2.14 each. Usage is increasing. The share price slumped 23.5% to 3.25p, which is a new low.
United Oil & Gas (LON: UOG) has raised £800,000 at 0.18p/share which will be used to support the ongoing farm-out process for the Walton-Morant licence in Jamaica. There is growing interest in this fam-out. The share price fell 10% to 0.18p.
Chemotherapy drug delivery technology developer CRISM Therapeutics (LON: CRTX) raised £874,000 from a placing at 12p/share and the retail offer generated £54,000. This will finance the manufacture of a batch of ChemoSeed for trials. The share price declined 4.35% to 11p.
Ex-dividends
Camellia (LON: CAM) is paying a final dividend of 260p/share and the share price dipped 300p to 5675p.
Next 15 Group (LON: NFG) is paying a final dividend of 10.6p/share and the share price declined 8.5p to 251.5p.
Premier Miton (LON: PMI) is paying an interim dividend of 3p/share and the share price slipped 3p to 74p.
Real Estate Investors (LON: RLE) is paying a dividend of 0.4p/share and the share price is unchanged at 32p.
Skillcast Group (LON: SKL) is paying a final dividend of 0.35p/share and the share price is unchanged at 47p.